MIST - Jefferies downgrades Milestone to hold cites product launch concerns June, 20 2023 06:18 PM Milestone Pharmaceuticals Inc. 2023-06-20 18:18:55 ET More on Milestone: Milestone Pharmaceuticals GAAP EPS of -$0.35 beats by $0.05, revenue of $1M Milestone Pharma receives $125M financing to support etripamil development For further details see: Jefferies downgrades Milestone to hold, cites product launch concerns